generics

GSK claps back at Teva in 'skinny' label case, arguing verdict doesn't threaten companies who act 'properly'
Fierce Pharma
Tue, 08/23/22 - 10:29 am
GSK
Teva Pharmaceutical
generics
legal
skinny labels
Endo loses Vasostrict patent battle as sales take a hit from generics
Endpoints
Sun, 08/21/22 - 09:43 pm
Endo International
Vasostrict
patents
generics
Eagle Pharmaceuticals
Expert: OGD on track to approve more generic drugs in FY2022
RAPS.org
Sun, 08/14/22 - 10:33 pm
FDA
generics
OGD
Bausch takes hit in Xifaxan patent feud, potentially paving the way for Norwich's IBS-D generic
Fierce Pharma
Mon, 08/1/22 - 10:33 am
Bausch Health
IBS-d
Xifaxan
legal
Norwich Pharmaceuticals
generics
Sanofi CEO Paul Hudson says his company is the Big Pharma 'least exposed' to generics this decade
Fierce Pharma
Thu, 07/28/22 - 12:23 pm
Sanofi
Paul Hudson
Pharma CEOs
generics
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
Fierce Pharma
Wed, 07/13/22 - 10:03 am
China
drug pricing
price cuts
AstraZeneca
Pfizer
Novartis
generics
Dr. Reddy’s launches extended-release rival to $200M Pfizer drug
Fierce Pharma
Mon, 07/11/22 - 05:52 pm
Dr Reddy's
Pfizer
overactive bladder
Toviaz
generics
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Fierce Pharma
Fri, 07/1/22 - 09:49 am
Novartis
spinoffs
generics
M&A
Sandoz
private equity
UCB lowers 2022 profit expectations amid Ukraine war, rising costs
Fierce Pharma
Mon, 06/27/22 - 10:09 am
UCB Pharma
Ukraine
Russia
generics
Teva, after Lupin deal, holds another Austedo generic challenger to a 2033 launch
Fierce Pharma
Sun, 06/12/22 - 08:19 pm
Teva Pharmaceutical
Austedo
generics
patents
tardive dyskinesia
Aurobindo
Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide
Xtalks
Wed, 06/8/22 - 11:04 pm
Novartis
Sandoz
biosimilars
generics
Bristol Myers settles anti-generic HIV drug scheme allegations for almost $11M
Endpoints
Wed, 06/8/22 - 10:18 am
Bristol Myers Squibb
legal
HIV
generics
competition
California
J&J takes Aurobindo to court over potential Erleada generic
Endpoints
Tue, 05/31/22 - 11:53 pm
JNJ
Aurobindo
legal
generics
Erleada
J&J's Momenta calls infringement against Viatris' Copaxone generic, but why now?
Fierce Pharma
Thu, 05/26/22 - 10:46 am
JNJ
Momenta Pharmaceuticals
Viatris
Copaxone
generics
drug manufacturing
Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO
Endpoints
Mon, 05/23/22 - 10:16 am
Europe
India
CROs
generics
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Novartis
Sandoz
generics
Roche
Esbriet
idiopathic pulmonary fibrosis
Teva settlement prevents Lupin from launching its Austedo generic until 2033
Fierce Pharma
Mon, 05/2/22 - 06:34 pm
Teva Pharmaceutical
tardive dyskinesia
Austedo
Lupin
generics
AstraZeneca staves off last Tagrisso copycat with settlement—for now
Fierce Pharma
Wed, 04/27/22 - 10:40 pm
AstraZeneca
Tagrisso
patents
legal
Alembic Pharmaceuticals
generics
Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court
Fierce Pharma
Fri, 04/15/22 - 01:54 pm
JNJ
Bristol Myers Squibb
Gilead Sciences
HIV
legal
anticompetitive practices
generics
FDA’s legislative wish list includes device cybersecurity, a generic exclusivity fix, and more
RAPS.org
Mon, 04/4/22 - 11:15 pm
FDA
regulatory
cybersecurity
MDUFA
devices
Medtech
generics

Pages